Cardioprotective Effects of Rosiglitazone Are Associated With Selective Overexpression of Type 2 Angiotensin Receptors and Inhibition of P42/44 MAPK

American Journal of Physiology - Heart and Circulatory Physiology - United States
doi 10.1152/ajpheart.00926.2005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Simultaneous Activation of P38 MAPK and P42/44 MAPK by ATP Stimulates the K+Current ITREKin Cardiomyocytes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Angiotensin II Type 2 Receptor Gene Transfer Elicits Cardioprotective Effects in an Angiotensin II Infusion Rat Model of Hypertension

Physiological Genomics
GeneticsPhysiology
2004English

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists in Rats With Heart Failure. Role of Kinins and Angiotensin II Type 2 Receptors.

Journal of Clinical Investigation
Medicine
1997English

Moderate Cardiac-Selective Overexpression of Angiotensin II Type 2 Receptor Protects Cardiac Functions From Ischaemic Injury

Experimental Physiology
NutritionPhysiologyDietetics
2011English

Overexpression of Type 1 Angiotensin II Receptors Impairs Excitation-Contraction Coupling in the Mouse Heart

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2011English

Divergent Effects of Corticotropin Releasing Hormone on Endothelial Cell Nitric Oxide Synthase Are Associated With Different Expression of CRH Type 1 and 2 Receptors

British Journal of Pharmacology
Pharmacology
2001English

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin-Angiotensin System

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Angiotensin Type 2 Receptors: Blood Pressure Regulation and End Organ Damage

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy